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Cell homeostasis results from the balance between cell capability to adapt or succumb to environmental stress. Mitochondria, in
addition to supplying cellular energy, are involved in a range of processes deciding about cellular life or death. The crucial role of
mitochondria in cell death is well recognized. Mitochondrial dysfunction has been associated with the death process and the onset
of numerous diseases. Yet, mitochondrial involvement in cellular adaptation to stress is still largely unexplored. Strong interest
exists inpharmacological manipulation of mitochondrial metabolismand signaling. TheyeastSaccharomyces cerevisiae has proven
a valuable model organism in which several intracellular processes have been characterized in great detail, including the retrograde
responsetomitochondrialdysfunctionand,morerecently,programmedcelldeath.Inthispaperwereviewexperimentalevidences
of mitochondrial involvement in cytoprotection and propose yeast as a model system to investigate the role of mitochondria in the
cross-talk between prosurvival and prodeath pathways.
1.Introduction
When faced with stressful conditions, cells display a molecu-
larresponsewhicheitherallowsthemtoadaptandsurviveor,
alternatively, cause cell demise. Depending on the level and
mode of stress, diﬀerent mechanisms have been described
for a number of modes in which cells die. The concept
of cellular demise and associated terminology have been
evolving since the ﬁrst characterization of apoptosis [1]a s
a form of programmed cell death (PCD), as opposed to an
accidental mode of cell death, that is, an unregulated process
termednecrosis.Mountingevidencehasbeencollectedinthe
lastthreedecadesoftheexistenceofatleastthreemajortypes
of regulated cell death mechanisms, depending on cell type
and death stimulus: type I, or apoptosis, that is of critical
importance forthesurvivalofmulticellularorganisms,being
involved in tissue homeostasis, embryonic development, and
in the immune response, type II, or autophagy, an important
multifunctional process whose main function is recycle of
cellular constituents, and type III, or necrosis (necroptosis),
which occurs after the exposure to severe stressful conditions
([2, 3] and references therein). These mechanisms do not
exclude each other and conditions which block, for example,
apoptosis, may cause autophagy or necrosis induction [4].
However, under certain conditions, cells can respond
to stress by activating prosurvival strategies leading to
cytoprotection. The most common pro-survival strategies
reported involve direct antagonizing of proapoptotic pro-
teins and increase in the expression levels of antiapoptotic
genes (see [5]). Another cytoprotective strategy adopted
by cells is preconditioning, which has been extensively
studied in the heart and the brain cells. It has been shown
that brief sublethal periods of ischemia/reperfusion induce
anti-apoptotic phenotype in these cells, protecting them
from ischemia/reperfusion mediated death [6–8]. Actually,
preconditioning with any apoptotic-inducing agent confers
the cells with cytoprotective phenotype. It appears that
this cytoprotective strategy is mediated by the increased
expression of a group of powerful anti-apoptotic genes, such
as genes encoding reactive oxygen species (ROS) scavengers,
heat shock proteins (HSPs), and other chaperones [9].2 The Scientiﬁc World Journal
Several molecular pathways causing cell adaptation have
been characterized, depending on the type of stress imping-
ing on the cell: (i) heat-shock response, (ii) unfolded protein
response, (iii) DNA damage response, (iv) response to
oxidativestress,(v)autophagy.Althoughbothanti-apoptosis
a n dc e l ls u r v i v a lp a t h w a y ss e r v et oc o u n t e r a c tP C D ,t h e s e
pathways are mechanistically distinct from the processes that
regulate cell death and there is cross-talk among them [9].
Forexample,oneofthemajormodesinwhichcellscoun-
teract a stress to remain alive is the activation of autophagy
promoting cell survival. Autophagy is a genetically regulated
bulk degradation program conserved from yeast to humans,
in which long-lived proteins and damaged organelles are
delivered to lysosomes in mammals or to the vacuoles in
yeast, where they are degraded and their components recy-
cled. The canonical autophagic pathway has been elucidated
at the molecular level, and the autophagy-related (ATG)
genes were ﬁrst identiﬁed in yeast, with homologous found
in all eukaryotes [10]. The contribution of such pathway to
autophagic cell death (type II PCD) as well as the molecular
mechanisms by which autophagy is activated as pro-survival
or prodeath cell stress response are yet unknown. There is
evidence of cross-talk between apoptosis and autophagy at
the molecular level through antiapoptotic B-cell lymphoma-
2 (Bcl2) family proteins [11].
A detailed description of all the modes of cell adaptation
and demise in response to stress conditions is beyond the
scope of this paper. Readers are referred to comprehensive
reviews on the topics [5, 9]. Here, we will rather focus
on the role of mitochondria in cell stress response and
cytoprotection.
2. MitochondrialPathways in
CellDeathandSurvival
Besides its well-recognized bioenergetic function, mitochon-
dria play an important role in many cell regulatory and
signaling events, including apoptosis [12]. Two main apop-
tosis signaling pathways have been delineated: the extrinsic
and intrinsic or mitochondrial pathway [13]. The extrinsic
pathway is mediated by a subgroup of tumor necrosis factor
receptors (TNFR) superfamily, so-called death receptors.
Binding of a ligand induces receptor clustering and for-
mation of a death-inducing signaling complex (DISC) (see
[13]). Via the Fas-associated death domain protein (FADD),
the adaptor molecule, this complex recruits multiple procas-
pase 8 molecules, resulting in the activation of caspase 8, one
ofthemembersofafamilyofcysteineproteasesthatfunction
as common death eﬀector molecules [14]. The intrinsic
pathway is regulated mainly by mitochondria. Internal
insults cause mitochondrial dysfunction, that is, energetic
failure, oxidative stress, lipid metabolism abnormalities, and
apoptosis sensitization. It involves stress-mediated release
of cytochrome c (cyt c), which then binds to apoptotic
protease activating factor 1 (Apaf-1), procaspase 9 and
possibly other molecules to form apoptosome, which causes
activation of caspase 3 (an eﬀector caspase). Pro- and anti-
apoptotic Bcl-2 proteins compete to regulate cyt c release
from mitochondria. Apart from the cyt c, other apoptogenic
factors are released from mitochondria as well, such as
apoptosis-inducingfactor(AIF),endonucleaseG,Omi/high-
temperature requirement protein A (HtrA2), or second
mitochondria-derived activator of caspase (Smac)/direct
inhibitor of apoptosis proteins (IAP) binding protein with
low PI (DIABLO). Mitochondrial membrane permeabiliza-
tion is a decisive event in the execution of apoptosis and
the associated bioenergetic deﬁciency is usually irreversible
and commits cells to die [15]. Activation of either apoptotic
pathway leads eventually to proteolytic degradation of
cellular components by caspases. Cross-talk between the two
pathways is provided by Bid, a pro-apoptotic member of Bcl-
2 protein family, activated by caspase 8 (see [16]).
Alternatively, in certain conditions, cells can respond to
mitochondrial stress by adaptation, thus ensuring cells sur-
vival.Processesthatleadtocytoprotectionthroughresistance
to apoptosis are probably best characterized in tumor cells,
given the altered regulation of the apoptotic process during
tumorigenesis. Upregulation of anti-apoptotic genes, such as
Bcl-2 and FLICE-like inhibitory protein (c-FLIP), as well as
a decrease in the expression of pro-apoptotic genes, such as
Bax, involved in mitochondrial permeabilization, are likely
the most common mechanisms involved in development of
anti-apoptotic phenotypes in cancer cells [17].
Dormancy stages, such as hibernation and diapauses, or
sporestagesinyeast,areexamplesofsurvivalstrategiesunder
long-term stressful environmental conditions. Some ani-
mals, like embryos of the brine shrimp, Artemia franciscana,
cansurviveunderanoxicconditionsatroomtemperaturefor
years [18], avoiding apoptotic or necrotic cell death, possibly
bytheabsenceofaregulatedmitochondrialpermeabilization
and cyt c release [19].
Several lines of evidence suggest that the primary
mechanism to eliminate dysfunctional, aged or excess mito-
chondria, promoting cell survival, is the selective form of
autophagy, termed mitophagy [20, 21]. It has also been
shown that the mitochondrial stress responses (MSRs) are
mediatedthroughtheactivityofthetranscriptionalcoactiva-
tor peroxisome-proliferator-activated receptor coactivator-1
(PGC-1)α [22]. PGC-1α a c t i v a t e sal a r g en u m b e ro fg e n e s
involved in respiration, oxidative metabolism, and uptake
and utilization of energy substrates [23].
Finally, it is of note that many cell death proteins,
including caspases, AIF, endonuclease G, and serine protease
Omi/HtrA2 and cyt c, besides their pro-apoptotic functions,
have important roles in cellular homeostasis [24]. Activation
of caspases is shown to be necessary for processes such as
terminal diﬀerentiation, activation, proliferation, and cyto-
protection [25]. Caspase-independent death eﬀectors, such
as AIF and Omi/HtrA2, are released from the mitochondrial
intermembrane space upon apoptosis induction, but these
proteins also have important functions in cellular redox
metabolism and/or mitochondrial biogenesis [26–28].
Beyond these circumstantial lines of evidence of a role
of mitochondria in cell decision for life and death, MSR
pathways which regulate the interplay between cell adapta-
tion and death are still poorly understood. With this respect,
signaling pathways involving the role of mitochondrialThe Scientiﬁc World Journal 3
calcium regulation in the cross-talk between autophagy and
apoptosis have been recently reviewed [29].
The yeast Saccharomyces cerevisiae has been a preferred
model organism in which major intracellular processes, such
as protein synthesis, mitochondrial biogenesis, retrograde
mitochondria-to-nucleus signaling pathway, the proteasome
machinery, and autophagy, have been identiﬁed for the ﬁrst
time and characterized in more details at the molecular
level. This model organism seems worth to be used in
research on how cells respond to mitochondrial dysfunction,
integrating death and growth signaling pathways. The best
known intracellular pathways by which yeasts respond to
mitochondrial dysfunctions are the programmed cell death
and retrograde signaling pathways, which will be reviewed in
the next paragraphs.
3.ProgrammedCellDeathinYeast
Apoptosis-like, autophagic and necrotic cell death pathways
have been detected in yeast cells exposed to diﬀerent intra-
and extracellular stresses. Thus, S. cerevisiae has been estab-
lished as an ideal model system to study PCD pathways more
in detail due to its easy handling and technical tractability,
together with the high level of phylogenetic conservation
of biochemical pathways and regulators between yeast and
mammals [30].
Yeast apoptosis, which has been largely investigated in
the last decade, shares most of the morphological and
biochemical hallmarks of mammalian apoptosis, such as
phosphatidylserine externalization to the outer layer of
the cytoplasmic membrane, DNA fragmentation, chromatin
condensation, ROS production, and involvement of speciﬁc
pro-apoptotic proteins, including cyt c, Aif1p, and Bcl-2
homology domain 3- (BH3-) containing protein [31–33].
Mitochondrial dysfunction has also been involved in yeast
PCD [34].
Why should a unicellular organism have developed and
conserved a highly coordinated suicide program during evo-
lution? Answers to this question are many. Microorganisms
are continuously exposed to various stressors and are well
known for their ability to adapt to constantly changing
conditions in their surroundings through altering genome
expression and metabolism [35, 36]. Apoptosis within yeast
colonies can occur under physiological conditions, when it is
perceived as an altruistic death of single cells that promotes
the long-term survival of the whole colony [37], or it can
be triggered externally by competing yeast strains or higher
eukaryotes [38]. The altruistic function of yeast PCD is
accomplished by eliminating infertile or otherwise damaged
cellsafterfailedmating,geneticrecombinantsnonadaptedto
the environment, and old cells during aging or development
of multicellular colonies. Nonclonal enemy strains, however,
can trigger death in the population by secretion of virus-
encoded killer toxins, in their competition for nutrients.
Higher eukaryotes, such as plants and animals, provoke
apoptosis in yeast cells as their mode of defense against
pathogenic fungi [39].
Apoptosis-inducing stimuli in yeast are diﬀerent: chem-
ical or physical stress, heterologous expression of human
proapoptotic proteins, or endogenous triggers, such as
mutations in genes involved in signal transduction pathways.
Acetic acid, produced normally by fermentation in S.
cerevisiae cells, is one of the compounds commonly used
to induce apoptosis in yeast [40]. Molecular mechanisms
and cell components of yeast PCD induced by acetic acid
(AA-PCD) together with acetic acid-stress adaptive response
have been characterized in detail (see [41]). In this paper we
propose that AA-PCD is a suitable model system to study the
role of mitochondrial pathways in cell stress response. To this
aim,herewemakeanoverviewonrecentachievementsinthe
mechanismsofyeastAA-PCDandfocusoninvestigationson
cytoprotective mechanisms at the mitochondrial level.
The molecular mechanisms in yeast AA-PCD have been
characterized in some details and are depicted in Figure 1.
Time course of events after the induction of AA-PCD
has been deﬁned in a work with exponentially growing S.
cerevisiae W303-1B cells, in which the minimum acetic acid
concentration suﬃcient to cause cell death was 80mM [40,
42]. Progressive loss of cell viability is complete after 200min
after AA-PCD induction. Correspondingly, AA-PCD cells
showed chromatin condensation and intact plasma mem-
brane; as well as DNA fragmentation, with the maximum
percentage at 150min [43–45].
The earliest event (15min) following acetic acid chal-
l e n g ei sR O Sp r o d u c t i o n ,w i t had i ﬀerent role for hydrogen-
peroxide and superoxide anion [46]. Hydrogen peroxide
appears to be a second messenger in AA-PCD cascade
of events, as also shown by AA-PCD inhibition by ROS
scavenger N-acetyl cysteine [47]. Catalase and superoxide
dismutase have been shown to modulate ROS level en route
to AA-PCD [48].
Mitochondria are strongly implicated in AA-PCD, with
the release of cyt c into the cytosol, the production of ROS,
the reduction in oxygen consumption and in mitochondrial
membrane potential as well as the loss of cytochrome c
oxidase (COX) function [31, 44]. Starting at 60min cyt c is
released (with a maximum at 150min) from intact coupled
mitochondria, and can function both as an electron donor
as well as ROS scavenger. Later on, AA-PCD mitochondria
become gradually uncoupled, and released cyt c is degraded,
possibly by yet unidentiﬁed proteases [44]. It is of interest
that AA-PCD can also occur without cyt c release, but with
a lower death rate compared to wild type (WT) cells, as it
has been shown in cyt c knockout cells [49]. The role of
cyt c in modulating AA-PCD has been further elucidated in
mutantcellsexpressingastablebutcatalyticallyinactiveform
of cyt c. The observation of an apoptotic resistant phenotype
associated to a decrease in ROS production and the lack of
cyt c release in this mutant suggests that mitochondrial cyt c
in its reduced state modulates AA-PCD independently on its
function as an electron carrier [50].
As in higher eukaryotes, proteolytic degradation of cell
components is activated in yeast PCD. Yeast contains a gene
encoding a metacaspase, named YCA1, which has a distant
amino acid sequence similarity to mammalian caspases [51,
52]. YCA1-encoded metacaspase shows cleavage speciﬁcity4 The Scientiﬁc World Journal
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Figure 1: AA-PCD pathways. Acetic acid enters in yeast cells and dissociates into acetate and protons causing intracellular acidiﬁcation.
H2O2 accumulates, SOD activity increases, while catalase activity is undetectable. En route to AA-PCD, cyt c is released and works as an
electron donor (cred) to mitochondrial respiratory chain and as superoxide anion (O2
−•)s c a v e n g e r( c ox) .I nal a t ep h a s e ,c y tci sd e g r a d e db y
unidentiﬁed proteases. Mitochondrial functions progressively decline with decrease in mitochondrial membrane potential (ΔΨ), respiratory
controlindex(RCI)andCOXactivity.Caspase-likeactivityincreasesinalatephase(redlines).Alternativeprogrammedcelldeathisinduced
by acetic acid in YCA1 and/or cyt c knockout cells or in mutant cyt c cells (blue lines).
diﬀerentfromthatofcaspases,sinceitcanhydrolyseproteins
after arginine or lysine residues but not after aspartate.
Nonetheless, both target substrates and the precise function
of the yeast metacaspase in PCD are still unknown [53].
Yeast cells lacking YCA1 gene undergo AA-PCD, with a lower
rate in respect to WT cells, showing that metacaspase is
dispensable for yeast apoptosis to occur. Although YCA1-
dependent caspase-like proteolytic activity was shown to
be induced in a late phase of AA-PCD (200min), the role
of YCA1 in this process appears to be independent of its
caspase-likeactivity[43].ItisofnotethatYCA1isimplicated
in cyt c release from mitochondria, but further investigations
are needed to elucidate the role of YCA1 in this process [49].
The occurrence of AA-PCD in cells lacking YCA1 or
respiratory deﬁcient cells due to cyt c mutations, with
features diﬀerent from wild-type cell AA-PCD, suggests
that acetic acid can activate alternative death pathways. In
these alternative death pathways mitochondria seem to play
diﬀerent roles [54].
4. The Mitochondrial Retrograde
PathwayinYeast
Cells can adapt to mitochondrial dysfunctions by activating
an evolutionally conserved communication pathway from
mitochondria to the nucleus, termed retrograde response
[55]. The best comprehension of components and molecular
details of the retrograde signaling have been obtained with
S. cerevisiae [56]. In these cells, the retrograde response
leads to a reconﬁguration in the expression of a subset of
nuclear genes enabling accommodation to changes in the
mitochondrial state. The prototypical target gene of the yeast
retrograde pathway is CIT2, which encodes the peroxisomal
isoform of citrate synthase functioning in the glyoxylate
cycle. CIT2 expression is largely increased in cells with
compromisedmitochondrialfunctions,suchasthoselacking
mitochondrial DNA (ρ0)[ 57]. Regulation of both basal and
upregulated expression of CIT2 is mainly dependent on
RTG genes, encoding regulatory proteins central to yeast
retrograde signaling (Figure 2). Rtg1p and Rtg3p are basic
helix-loop-helix/leucine zipper (bHLH/Zip) transcription
factors that interact as a heterodimer to bind target sites
called R boxes (GTCAC) located in the promoter region
of the retrograde target genes [58]. Activation of Rtg3p
as an active transcriptional unit correlates with its partial
dephosphorylationanditstranslocationwithRtg1pfromthe
cytoplasm to the nucleus [59]. Crucial to this translocation
is Rtg2p, a cytoplasmic protein with an N-terminal ATP-
binding domain, belonging to the actin/Hsp70/sugar kinase
superfamily [60, 61]. Rtg2p acts upstream of the Rtg1/Rtg3p
complex, being both a proximal sensor of the mitochondrial
dysfunctionandatransducerofmitochondrialsignals.Rtg2p
regulates Rtg1/3p localization through the reversible binding
with Mks1p, a negative regulator of the RTG pathway,
acting in the cytoplasm downstream of Rtg2p but upstream
of Rtg1/3p [62]. Mks1p promotes the phosphorylation of
Rtg3p, thus inhibiting the nuclear translocation of Rtg1/3p
[63, 64]. Other positive and negative regulators of the RTGThe Scientiﬁc World Journal 5
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Figure 2: Signaling pathways possibly involved in the interplay between cell death and cytoprotection processes in yeast cells in response
to acetic acid stress. Acetic acid causes intracellular acidiﬁcation, mitochondrial dysfunction, and cell death. TOR pathway is involved in
the signaling of AA-PCD; rapamycin inhibition of TOR can trigger autophagy and RTG target gene expression. Dotted lines indicate the
hypothetical signaling pathways in AA-PCD regulation in response to mitochondrial dysfunction, on the basis of indirect experimental
evidence (see text for details). Intracellular acidiﬁcation stimulates RAS-cAMPsignaling pathway, causing mitochondrial dysfunction, which
may lead to AA-PCD or activate retrograde response inducing AA-PCD resistance. RAS pathway negatively regulates Mks1p, a negative
regulator of RTG pathway. Positive and negative regulators of RTG pathway are shown in blue and red, respectively. TOR signaling is found
at the crossroad of RTG, AA-PCD, and autophagy pathways.
pathway have been characterized, including Grr1p which
mediates ubiquitination of Mks1p [61]; Bmh1p and Bmh2p,
belonging to 14-3-3 protein family, which bind to Rtg3p and
keepitinaninactivestate[65]andLst8p,anessentialprotein
suggested to negatively regulate the RTG pathway with one
site upstream and the other site downstream of Rtg2p
[66]. The physiological role of the RTG pathway has been
essentially provided by the identiﬁcation of RTG-dependent
target genes, including CIT2, DLD3, encoding a D-lactate
dehydrogenase, and CIT1, ACO1, IDH1/2, encoding the ﬁrst
three enzymes in the TCA cycle [67, 68]. Thus, the RTG
pathway is involved in glutamate biosynthesis, to meet the
demand of nitrogen supply for biosynthetic reactions, and
in mitochondrial DNA maintenance, through regulation of
ACO1 [69, 70]. RTG-independent retrograde response to
mitochondrial dysfunction has also been shown [71].
It is of note that the RTG pathway is linked to other
signaling pathways, such as TOR (target of rapamycin)
pathway which inhibits Rtg1/3-dependent gene expression
[72]. Lst8p, a central component of the two TOR kinase
complexes, TOR1 and TOR2, is suggested to have a role
in connecting the RTG and TOR pathways. However, it
is clear that these two pathways do not overlap but act
in parallel to converge on Rtg1/3p [73]. At this regard, it
has also been proposed that Aup1, a possible part of a
signaling mechanism that functionally overlaps with TOR,
promotes the activation of RTG pathway under mitophagic
conditions [74] .T h er e t r o g r a d er e s p o n s ei sa l s or e l a t e d
to the Ras-cAMP signaling pathway. Ras2p potentiates
the retrograde response and this action is likely mediated
through the negative eﬀect of the RAS-cAMP pathway on
Mks1p [75]. In terms of pro-survival and adaptive response,6 The Scientiﬁc World Journal
the RTG-dependent signaling pathway in yeast and the NF-
κB stress response active in mammalian cells appear to be
involved in a conserved mechanism of cell stress response,
further validating yeast as a model to study mitochondrial
stress response pathways [76].
5. CytoprotectioninYeastAA-PCD
Acetic acid-stress sensitivity of yeast cells strongly depends
on the extracellular environment. Indeed, AA-PCD is
induced in yeast cells growing on glucose as carbon source
at pH 3.0. At neutral pH, S. cerevisiae cells are able to grow
on acetic acid medium as the sole carbon and energy source.
Under this condition, the acid is found in a dissociated
form,andacetateistransportedacrosstheplasmamembrane
through a low-aﬃnity electroneutral proton symport system
(see [41]). The ability of S. cerevisiae to use acetic acid as
the only carbon and energy source depends on both the uti-
lization of acetyl-CoA in the tricarboxylic acid (TCA) cycle,
mainly for ATP synthesis and biosynthetic purposes, and on
the production of succinate through the glyoxylate cycle as
an anaplerotic pathway [77–79]. However, acetate transport
and its metabolism are inhibited under glucose repression
in S. cerevisiae due to the activation of pathways responsible
for downregulation of respiration and gluconeogenesis [80].
M o r e o v e r ,a tl o wp H ,a c e t i ca c i di si nt h eu n d i s s o c i a t e d
state which has been shown to penetrate cells through the
plasma membrane by simple diﬀusion [81] facilitated by
the Fps1p aquaglyceroporin channel [82]. More neutral pH
inside the cell causes its dissociation into acid anions and
protons, which leads to cytoplasmic acidiﬁcation, thereby
inhibitingimportantmetabolicprocesses[83]andincreasing
cell toxicity.
S. cerevisiae c e l l sh a v eb e e ns h o w nt ob ep r o t e c t e d
from AA-PCD following 30min preconditioning in low pH
medium set by HCl prior to PCD induction [42]. Adaptation
is accompanied by increasing levels of both catalase and
superoxide dismutase activities, together with a decrease
in intracellular levels of ROS [46]. It is of note that en
route to AA-PCD the catalase activity is undetectable [42].
Whether the catalase undergoes enzyme inactivation and/or
degradation in the AA-PCD cells remains to be established.
However, unlike with mouse cell lines in which autophagy
occurs as a result of selective catalase degradation [84],
autophagy proved to be absent in AA-PCD [85].
At low pH, acetic acid activates an adaptive response
in yeast cells mediated by two mitogen-activated protein
(MAP) kinases, Hog1p, involved in the high-osmolarity
glycerol (HOG) signaling pathway, and Slt2p, involved in
cell integrity pathway. Acetic acid adaptation is mediated
by Hog1p-dependent phosphorylation of Fps1p resulting
in its ubiquitination, endocytosis, and degradation, thus
blocking acetic acid uptake into the cell [82]. The Hog1p-
dependent degradation of Fps1p has been hypothesized as a
mechanism of the protection from the AA-PCD exerted by
acid preconditioning [86]. Yet, this mechanism is not likely
to be active in acid-stressed preconditioned yeast cells, since
acetic acid is absent in the pre-conditioning medium.
In acid-stress-adapted cells, acetic acid treatment does
not cause any increase in intracellular ROS production [42].
Since ROS are mainly produced by mitochondria, a mod-
ulation in MSR may be hypothesized in this case. Figure 2
shows certain signaling pathways involved in cell response
to mitochondrial dysfunction that may have a role in the
cross-talk between cell death and adaptation mechanisms
activated by acetic acid stress in yeast. The best characterized
mechanism of response to mitochondrial dysfunction in
yeast cells is the RTG pathway. RTG-dependent retrograde
response to mitochondrial dysfunction seems to have a
role in adaptation of S. cerevisiae cells to acetic acid stress,
as suggested by the up-regulation of CIT2 mRNA, the
prototypical RTG-target gene, in respiratory deﬁcient cells
lacking mitochondrial DNA (ρ0), with respect to respiratory
competent (ρ+) cells, both grown in the low pH medium
used for cell pre-conditioning. On the other hand, RTG
pathway is inactive in conditions in which cells are sensitive
to AA-PCD induction, since in this case no up-regulation of
CIT2 mRNA in ρ0 with respect to ρ+ cells is measured (data
not shown).
TOR kinase signaling pathway that regulates cell growth
in response to nutrient availability has been shown to be
involved in the AA-PCD [87]. Although the RTG pathway
is linked to TOR signaling, which represses transcription
of RTG target genes, retrograde response to mitochondrial
dysfunction has shown to be separable from TOR regulation
of retrograde target gene expression [73]. Note that acetic
acid has been identiﬁed as an extracellular mediator of
cell death during chronological aging in yeast [88, 89].
This process involves the RAS-cAMP-PKA and the SCH9
signaling pathways, which are known to control yeast cell
adaptation to nutrient availability as well as chronological
lifespan in yeast [90, 91]. SCH9, the yeast homologue of
Akt in mammals, is a major component of TOR pathway
[92]. Consistently, intracellular acidiﬁcation, induced by
weak acids on a low pH medium, stimulates the RAS-cAMP
signalingpathway,negativelyregulatingcellviability[93,94].
cAMP-PKA signaling pathway plays an important role in
coordination of mitochondrial function with environmental
(nutritional) changes in yeast. The inappropriate activation
of PKA can lead to the production of dysfunctional, ROS
generating mitochondria, and apoptosis [95].
6. Conclusions and Perspectives
Intracellular pathways that regulate cellular resistance to cell
death are intimately connected to the regulation of cellular
metabolism. Mitochondria make a crucial link between
metabolic and apoptotic processes, since they have a central
role in the regulation of both [96].
Deciphering molecules and pathways involved in ﬁne-
tuning of PCD and cytoprotective processes is of paramount
importance in biomedicine, since their dysregulation lays
behind the pathogenesis of diseases such as cancer. Indeed,
increased cellular metabolism and apoptotic resistance
are two components of cellular transformation. Mito-
chondrial signaling involved in the responses of cells toThe Scientiﬁc World Journal 7
metabolic transitions and physiological stresses remains
largely unexplored. Strong interest exists in pharmacological
manipulation of mitochondrial metabolism and signaling
[97].
The fermenting yeast S. cerevisiae, which has the ability
to switch on and oﬀ respiration in response to changes in the
carbon source, and tumor cells shares several features from
themetabolicpointofview[98,99].Agenome-wideanalysis
in this model organism suggests that retrograde response to
mitochondrial dysfunction plays a role in mutagenesis and
genome instability and may be implicated in carcinogenesis
[100]. Recent progress in the elucidation of conserved PCD
pathways in the yeast S. cerevisiae, together with the large
amount of knowledge available about cell biology and
metabolism in this model organism, provides a valuable
experimental tool to study the relations between PCD
regulators and components of cytoprotective intracellular
signaling activated by cell stress.
Limitations to the use of a unicellular model organism
arepresentintranslationintomulticellularorganismsorinto
clinical relevant conditions with modiﬁed stress responses,
as in aging or diabetes. Indeed, the molecular mechanisms
underlying pathological conditions faithfully recapitulated
in yeast will ultimately have to be tested in human cell and
animal models. Yet, understanding the complex intracellular
regulatory network integrating cell adaptation and death
pathways through MSR pathways in yeast is a challenge for
future investigations, which will shed light on many aspects
of eukaryotic cell homeostasis.
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